Home/VALANX Biotech/Michael Lukesch
ML

Michael Lukesch

CEO & Founder

VALANX Biotech

Therapeutic Areas

VALANX Biotech Pipeline

DrugIndicationPhase
GoldenSite™-enabled next generation protein-drug-conjugatesNot Disclosed (Oncology focus)Preclinical